Jerrold J. Ellner

RH Provider

Thumbnail

Jerrold J. Ellner, M.D.

Specialties:
Infectious Disease, Internal Medicine

Interests:
Internal Medicine, Infectious Disease

Education

Post-Doctoral Training, 1975-76, Johns Hopkins Hospital (Chief Medical Resident,
Assistant Chief of Service)
Research Fellowship, 1972-75, National Institute of Allergy and Infectious Diseases
(NIAID), NIH
Residency Training, 1970-72, Johns Hopkins Hospital
MD, 1970, Johns Hopkins University
BA, 1966, Cornell University
Aetna, Inc.
America's Choice Provider Network (ACPN)
Cigna Healthcare
Clover Health Plans
Devon Health Services/ULLICO
QualCare
Horizon NJ Health
Horizon NJ Total Care (HNJH)
Horizon PPO Network
Medicaid
Medicare
Private Healthcare Systems
Prime Health Services, Inc.
Qual Care HMO
Qual Care PPO
Emblem Health
UHC Comm / Oxford
United Healthcare Community Plan (formerly AmeriChoice of NJ, Inc.)
WellCare Health Plans
Magnacare
University Hospital, Newark
B.A., Cornell University (09/01/1962-06/01/1966)
M.D., Johns Hopkins University (09/01/1970-05/27/1970)
Johns Hopkins Hospital, Baltimore, MD, USA (07/01/1970-06/30/1971)
Resident-Internal Medicine, Johns Hopkins Hospital, Baltimore, MD, USA (07/01/1971-06/30/1976)
Fellowship-Infectious Diseases, National Institutes of Health, Bethesda, MD, USA (07/01/1972-06/30/1975)
Internal Medicine, Infectious Disease Education Post-Doctoral Training, 1975-76, Johns Hopkins Hospital (Chief Medical Resident, Assistant Chief of Service) Research Fellowship, 1972-75, National Institute of Allergy and Infectious Diseases (NIAID), NIH Residency Training, 1970-72, Johns Hopkins Hospital MD, 1970, Johns Hopkins University BA, 1966, Cornell University
Locations
Provider Biography
Dr. Ellner is a Professor and currently serves as the Director of Research Innovations for the Center for Emerging and Re-Emerging Pathogens, in the Department of Medicine, Division of Infectious Diseases, at the Rutgers New Jersey Medical School, where he served as the former Chief of the Division of Infectious Diseases for 10 years. Dr. Ellner has studied the immunopathogenesis of TB and TB in HIV through research collaborations in Uganda and Brazil. He has conducted clinical trials on the prevention and treatment of TB, as well as the first HIV/AIDS Vaccine Trial in Africa. His research group was the first to show that TB accelerated the course of HIV infection by activating viral replication in latently infected cells. He is one of the principal architects of the Uganda-Case Western Reserve University Research Collaboration, a founding member of the Academic Alliance for AIDS Prevention and Care in Africa, which developed the Infectious Diseases Institute at Makerere University, and the founding director of the TB Research Unit at Case Western Reserve University. He is PI of an International Collaboration for Infectious Diseases Research (ICIDR) program in Brazil and the TB ? Clinical Diagnostics Research Consortium (CDRC). With more than 300 publications on TB, Dr. Ellner has trained a number of current academic leaders in infectious diseases.